Compare POR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | POR | HAE |
|---|---|---|
| Founded | 1889 | 1971 |
| Country | United States | United States |
| Employees | 2915 | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.8B |
| IPO Year | 1994 | 1996 |
| Metric | POR | HAE |
|---|---|---|
| Price | $44.03 | $103.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $52.27 | ★ $111.50 |
| AVG Volume (30 Days) | ★ 1.3M | 476.7K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.98% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.97 | 0.72 |
| Revenue | ★ $3,576,000,000.00 | $910,373,000.00 |
| Revenue This Year | $3.55 | $6.21 |
| Revenue Next Year | $7.46 | $5.54 |
| P/E Ratio | ★ $45.64 | $145.96 |
| Revenue Growth | ★ 3.95 | N/A |
| 52 Week Low | $43.15 | $48.17 |
| 52 Week High | $54.62 | $110.45 |
| Indicator | POR | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 25.85 | 48.26 |
| Support Level | $43.26 | $100.53 |
| Resistance Level | $54.33 | $110.01 |
| Average True Range (ATR) | 0.96 | 2.33 |
| MACD | -0.25 | -0.91 |
| Stochastic Oscillator | 15.30 | 1.89 |
Portland General Electric is a regulated electric utility providing generation, transmission, and distribution services in a service territory that includes about half of all Oregon residents and two-thirds of the state's business activity. The company owns (wholly or through joint ventures) 3.6 gigawatts of gas, coal, wind, and hydro generation, along with 300 megawatts of energy storage. In February 2026, PGE proposed acquiring utilities in Washington state from Berkshire Hathaway Energy.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.